Reata Pharmaceuticals Inc... (RETA)
NASDAQ: RETA
· Real-Time Price · USD
172.36
0.04 (0.02%)
At close: Sep 25, 2023, 10:00 PM
Reata Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 48.84M | 84.94M | 42.31M | 31.92M | 147.15M | 531.98M | 590.26M | 713.21M | 755.71M | 777.62M |
Short-Term Investments | 281.37M | 236.02M | 345.2M | 403.96M | 334.32M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 10.84M | 6.17M | 284K | 142K | 147K | 152K | 160K | 3.21M | 3.93M | 4.64M |
Receivables | 22.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 2.94M | 5.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 46.03M | 5.87M | 355.46M | 9.23M | 9.74M | 5.36M | 6.22M | 8.45M | 11.97M | 27.9M |
Total Current Assets | 401.85M | 332.54M | 397.77M | 445.1M | 491.21M | 537.34M | 596.48M | 721.66M | 767.68M | 805.52M |
Property-Plant & Equipment | 89.9M | 114.87M | 116.44M | 138.4M | 140.19M | 142.38M | 138.38M | 6.98M | 6M | 4.92M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 100.74M | 121.04M | 116.72M | 138.54M | 140.34M | 142.53M | 138.54M | 10.19M | 9.93M | 9.56M |
Total Assets | 502.59M | 453.58M | 514.49M | 583.64M | 631.55M | 679.87M | 735.02M | 731.85M | 777.61M | 815.08M |
Account Payables | 19.86M | 14.45M | 18.71M | 7.52M | 7.75M | 9.02M | 13.51M | 1.74M | 8.41M | 8.26M |
Deferred Revenue | 84.53M | n/a | n/a | n/a | n/a | 755K | 1.65M | 2.56M | 3.09M | 3.89M |
Short-Term Debt | 2.46M | 3.21M | n/a | 5.25M | 8.22M | 5.14M | 3.14M | n/a | n/a | n/a |
Other Current Liabilities | 102.78M | 36.94M | 40.25M | 37.94M | 30.35M | 28.71M | 35.7M | 116.98M | 109.6M | 102.21M |
Total Current Liabilities | 125.09M | 54.6M | 58.96M | 50.71M | 46.33M | 43.62M | 53.99M | 121.28M | 121.1M | 114.36M |
Long-Term Debt | 90.42M | 117.93M | 119.46M | 135.46M | 142.51M | 136.44M | 136.03M | n/a | n/a | n/a |
Other Long-Term Liabilities | 199.79M | 411.72M | 401.76M | 392.96M | 374.08M | 372.02M | 359M | 354.58M | 342.68M | 331.39M |
Total Long-Term Liabilities | 290.2M | 529.66M | 521.23M | 528.42M | 516.59M | 508.46M | 495.03M | 354.58M | 342.68M | 331.39M |
Total Liabilities | 415.3M | 584.25M | 580.19M | 579.13M | 562.91M | 552.08M | 549.03M | 475.87M | 463.78M | 445.75M |
Total Debt | 166M | 117.93M | 119.46M | 140.71M | 150.73M | 141.59M | 136.03M | n/a | n/a | n/a |
Common Stock | 38K | 38K | 37K | 37K | 37K | 36K | 36K | 36K | 36K | 36K |
Retained Earnings | -1.49B | -1.68B | -1.57B | -1.48B | -1.4B | -1.33B | -1.26B | -1.17B | -1.1B | -1.03B |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 87.29M | -1.68B | -65.69M | 4.52M | -1.4B | 127.78M | -1.26B | 255.98M | 313.83M | 369.33M |
Total Investments | 281.37M | 236.02M | 345.2M | 403.96M | 334.32M | n/a | n/a | n/a | n/a | n/a |